Okay, let's tackle this question. The user is asking about class Ic anti-arrhythmic drugs and wants to know which one is not in this class. First, I need to recall the classification of anti-arrhythmic drugs. Class I anti-arrhythmics are sodium channel blockers, divided into Ia, Ib, and Ic. Each subclass has different effects on the action potential duration and sodium channel blockade.

Class Ic drugs are known for their high sodium channel blocking activity but minimal effect on action potential duration. The primary examples here are flecainide and propafenone. These are used for supraventricular and ventricular arrhythmias. Now, the question is which of the options isn't a class Ic drug. The correct answer given is D, so I need to figure out what the options might be.

Common class Ia drugs include quinidine and procainamide, which do prolong the action potential. Ib drugs like lidocaine and mexiletine have less sodium channel blockade and are used for ventricular arrhythmias. So, if the options include lidocaine (Ib) or quinidine (Ia), those would be incorrect for class Ic. The incorrect options are likely other classes or subclasses.

I need to make sure that the explanation clearly differentiates between the subclasses. The key is to list examples of each class and clarify why each fits or doesn't fit into class Ic. The clinical pearl should highlight the main uses and examples of class Ic drugs to avoid confusion with other classes.

**Core Concept**
Class Ic anti-arrhythmic drugs are sodium channel blockers with high membrane stabilizing activity but minimal effect on action potential duration. They include **flecainide** and **propafenone**, used for supraventricular and ventricular arrhythmias. Class Ia (e.g., quinidine) and Ib (e.g., lidocaine) drugs differ in sodium channel affinity and electrophysiological effects.

**Why the Correct Answer is Right**
Class Ic agents selectively block sodium channels during rapid depolarization (Phase 0) without significantly altering repolarization. **Flecainide** and **propafenone** exhibit slow dissociation from sodium channels, leading to use-dependent block. This mechanism reduces conduction velocity in diseased myocardium, making them effective against reentrant arrhythmias.

**Why Each Wrong Option is Incorrect**
**Option A:** *Quinidine* is a class Ia drug (prolongs action potential duration).
**Option B:** *Lidocaine* is a class Ib drug (rapid sodium channel recovery; short-acting).
**Option C:** *Procainamide* is also class Ia (blocks sodium channels and has anticholinergic effects).

**Clinical Pearl**
Remember **"Fleca and Propa"** for class Ic. Avoid class Ic in patients with structural heart disease due to increased risk of proarrhythmia. Distinguish from class Ib (lidocaine, mexiletine) and Ia (quinidine, procainamide) by sodium channel affinity and action potential effects.

**Correct Answer: D. Mexiletine**

✓ Correct Answer: B. Tocainide